Treace Medical Concepts Stock Today
| TMCI Stock | USD 8.52 0.04 0.47% |
Performance10 of 100
| Odds Of DistressLess than 27
|
Treace Medical is trading at 8.52 as of the 30th of November 2024. This is a 0.47 percent decrease since the beginning of the trading day. The stock's open price was 8.56. Treace Medical has about a 27 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat ok performance during the last 90 days. Equity ratings for Treace Medical Concepts are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 23rd of April 2021 | Category Healthcare | Classification Health Care |
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida. The company has 62.3 M outstanding shares of which 2.99 M shares are at this time shorted by private and institutional investors with about 4.19 trading days to cover. More on Treace Medical Concepts
Moving together with Treace Stock
Moving against Treace Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Treace Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsTreace Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Treace Medical's financial leverage. It provides some insight into what part of Treace Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treace Medical Concepts (TMCI) is traded on NASDAQ Exchange in USA. It is located in 100 Palmetto Park Place, Ponte Vedra, FL, United States, 32081 and employs 516 people. Treace Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 533.26 M. Treace Medical Concepts conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 62.3 M outstanding shares of which 2.99 M shares are at this time shorted by private and institutional investors with about 4.19 trading days to cover.
Treace Medical Concepts currently holds about 101.53 M in cash with (34.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83.
Check Treace Medical Probability Of Bankruptcy
Ownership AllocationTreace Medical Concepts shows a total of 62.3 Million outstanding shares. Over half of Treace Medical's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Treace Ownership Details
Treace Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| State Street Corp | 2024-06-30 | 957.5 K | |
| Kent Lake Capital Llc | 2024-06-30 | 750 K | |
| Millennium Management Llc | 2024-06-30 | 686 K | |
| Kornitzer Capital Management Inc | 2024-09-30 | 526.9 K | |
| Gagnon Advisors, Llc | 2024-09-30 | 489.9 K | |
| Marshall Wace Asset Management Ltd | 2024-06-30 | 463 K | |
| Northern Trust Corp | 2024-09-30 | 458.2 K | |
| Jpmorgan Chase & Co | 2024-06-30 | 400.5 K | |
| Charles Schwab Investment Management Inc | 2024-09-30 | 391 K | |
| Armistice Capital, Llc | 2024-09-30 | 6.2 M | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 5.7 M |
Treace Medical Historical Income Statement
Treace Stock Against Markets
Treace Medical Corporate Management
| Shana Zink | Senior Reimbursement | Profile | |
| Julie Dewey | Chief Officer | Profile | |
| Scot JD | Chief Secretary | Profile | |
| Thomas Timbie | Independent Director | Profile | |
| John Treace | Founder CEO | Profile | |
| Sean Scanlan | Chief Officer | Profile | |
| Nathan Minnich | Senior Marketing | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.99) | Revenue Per Share 3.274 | Quarterly Revenue Growth 0.106 | Return On Assets (0.17) | Return On Equity (0.51) |
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.